Trial Roundup

Trial Roundup

ASH Clinical News’ Associate Editors select clinical trials to keep an eye on

Trial Roundup: PRTX-100 for Immune Thrombocytopenia, APR-246 for Myeloid Neoplasms, and more

ASH Clinical News' Associate Editors select clinical trials to keep an eye on in leukemia, bleeding disorders, and lymphoma & myeloma.David Steensma, MD Dana-Farber Cancer Institute A...

Vadastuximab Talirine in Higher-Risk MDS, Low-Dose Rituximab for Acquired TTP, and more

ASH Clinical News' Associate Editors select clinical trials to keep an eye on in leukemia, bleeding disorders, and lymphoma & myeloma.David Steensma, MD Dana-Farber Cancer Institute Study...

Evaluating Acalabrutinib for Hematologic Malignancies, Minimizing Menorrhagia in Women With Type 1 Von Willebrand...

LEUKEMIA David Steensma, MD Dana-Farber Cancer Institute Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute...

Introducing the Beat AML Master Trial, and more

The Beat AML Master Trial Study Design: Observational, prospective cohort study Study Start Date: November 2016 Estimated Study Completion Date: November 2023 Study Status:...

Clinical Trials for Rare Diseases

Below, we take a look at ongoing clinical trials for rare diseases. In addition to searching for new therapeutic targets and developing novel drugs...

Biomarker-Directed Trial for AML or MDS, Safety and Efficacy of BMN 270 for Hemophilia,...

LEUKEMIA David Steensma, MD Dana-Farber Cancer Institute Controlled Study of Rigosertib Versus Physician’s Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE) (NCT02562443) Study...

T Cell Therapy for Previously Treated Multiple Myeloma, Emicizumab in Hemophilia A Patients With...

LEUKEMIA David Steensma, MD Dana-Farber Cancer Institute A Two-Arm Phase II Clinical Study of the Clinical Efficacy and Safety of Tosedostat in Patients With Myelodysplastic Syndromes (MDS)...

Lenalidomide Plus R-CHOP in DLBCL, New Gene Therapies for Hemophilia B , and more

LEUKEMIA David Steensma, MD Dana-Farber Cancer Institute A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3...

CAR T Cells in AML, Preventing VTE in Cancer Patients, and more

LEUKEMIA David Steensma, MD Dana-Farber Cancer Institute Phase 1b Acute Myelogenous Leukemia (AML) Study with ABT-199 + Decitabine or Azacitidine (Chemo Combo) (NCT02203773) Study Design: Phase Ib,...

4D Study, Rivaroxaban, and more

BLEEDING DISORDERS Alice Ma, MD University of North Carolina School of Medicine This month’s benign hematology section focuses on the prevention and management of venous thromboembolism (VTE). The...
Advertisement

Current Issue

October 2017, Volume 3, Issue 12

This issue features a look at hospital ranking systems, the risks and benefits of opioids for pain management, and more.